MARATTO

article · Frontiers in Pharmacology

Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial

20242 citationsOpen accessMenoufia University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

clinicaltrials.gov, identifier NCT04834557.

Research topics

  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Systemic Lupus Erythematosus Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3389/fphar.2024.1445708

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.